These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 8620677

  • 1. Assessment of the pharmacokinetic interaction between zileuton and digoxin in humans.
    Awni WM, Hussein Z, Cavanaugh JH, Granneman GR, Dubé LM.
    Clin Pharmacokinet; 1995; 29 Suppl 2():92-7. PubMed ID: 8620677
    [Abstract] [Full Text] [Related]

  • 2. Lack of pharmacokinetic interaction between zileuton and phenytoin in humans.
    Samara E, Cavanaugh JH, Mukherjee D, Granneman GR.
    Clin Pharmacokinet; 1995; 29 Suppl 2():84-91. PubMed ID: 8620675
    [Abstract] [Full Text] [Related]

  • 3. Effect of zileuton on theophylline pharmacokinetics.
    Granneman GR, Braeckman RA, Locke CS, Cavanaugh JH, Dubé LM, Awni WM.
    Clin Pharmacokinet; 1995; 29 Suppl 2():77-83. PubMed ID: 8620674
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic interactions between zileuton and prednisone.
    Awni WM, Cavanaugh JH, Tzeng TB, Witt G, Granneman GR, Dubé LM.
    Clin Pharmacokinet; 1995; 29 Suppl 2():105-11. PubMed ID: 8620666
    [Abstract] [Full Text] [Related]

  • 5. The influence of multiple oral doses of zileuton on the steady-state pharmacokinetics of sulfasalazine and its metabolites, sulfapyridine and N-acetylsulfapyridine.
    Awni WM, Braeckman RA, Locke CS, Dubé LM, Granneman GR.
    Clin Pharmacokinet; 1995; 29 Suppl 2():98-104. PubMed ID: 8620678
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic interaction of sparfloxacin and digoxin.
    Johnson RD, Dorr MB, Hunt TL, Conway S, Talbot GH.
    Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539
    [Abstract] [Full Text] [Related]

  • 7. The pharmacokinetic and pharmacodynamic interactions between the 5-lipoxygenase inhibitor zileuton and the cyclo-oxygenase inhibitor naproxen in human volunteers.
    Awni WM, Braeckman RA, Cavanaugh JH, Locke CS, Linnen PJ, Granneman GR, Dubé LM.
    Clin Pharmacokinet; 1995 Feb; 29 Suppl 2():112-24. PubMed ID: 8620667
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and pharmacodynamics of zileuton after oral administration of single and multiple dose regimens of zileuton 600mg in healthy volunteers.
    Awni WM, Braeckman RA, Granneman GR, Witt G, Dubé LM.
    Clin Pharmacokinet; 1995 Feb; 29 Suppl 2():22-33. PubMed ID: 8620668
    [Abstract] [Full Text] [Related]

  • 11. The pharmacokinetic and pharmacodynamic interaction between zileuton and terfenadine.
    Awni WM, Cavanaugh JH, Leese P, Kasier J, Cao G, Locke CS, Dube LM.
    Eur J Clin Pharmacol; 1997 Feb; 52(1):49-54. PubMed ID: 9143867
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The pharmacokinetics of zileuton in healthy young and elderly volunteers.
    Braeckman RA, Granneman GR, Locke CS, Machinist JM, Cavannaugh JH, Awni WM.
    Clin Pharmacokinet; 1995 Feb; 29 Suppl 2():42-8. PubMed ID: 8620670
    [Abstract] [Full Text] [Related]

  • 14. Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on the pharmacokinetics of oral contraceptives, warfarin, and digoxin in healthy participants.
    Devineni D, Manitpisitkul P, Vaccaro N, Bernard A, Skee D, Mamidi RN, Tian H, Weiner S, Stieltjes H, Sha S, Rothenberg P.
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):41-53. PubMed ID: 25345427
    [Abstract] [Full Text] [Related]

  • 15. Cilomilast: pharmacokinetic and pharmacodynamic interactions with digoxin.
    Zussman BD, Kelly J, Murdoch RD, Clark DJ, Mbchb, Schubert C, Collie H.
    Clin Ther; 2001 Jun; 23(6):921-31. PubMed ID: 11440291
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Darexaban (YM150), an oral direct factor Xa inhibitor, has no effect on the pharmacokinetics of digoxin.
    Kadokura T, Groenendaal D, Heeringa M, Mol R, Verheggen F, Garcia-Hernandez A, Onkels H.
    Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):1-9. PubMed ID: 23754514
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of lapatinib on oral digoxin absorption in patients.
    Koch KM, Smith DA, Botbyl J, Arya N, Briley LP, Cartee L, White JH, Beyer J, Dar MM, Chung HC, Chu Q, Bang YJ.
    Clin Pharmacol Drug Dev; 2015 Nov; 4(6):449-53. PubMed ID: 27137717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.